Eames B Frank, de la Fuente Luis, Helms Jill A
Department of Orthopaedic Surgery, University of California at San Francisco, California, USA.
Birth Defects Res C Embryo Today. 2003 May;69(2):93-101. doi: 10.1002/bdrc.10016.
From a traditional viewpoint, skeletal elements form by two distinct processes: endochondral ossification, during which a cartilage template is replaced by bone, and intramembranous ossification, whereby mesenchymal cells differentiate directly into osteoblasts. There are inherent difficulties with this historical classification scheme, not the least of which is that bones typically described as endochondral actually form bone through an intramembranous process, and that some membranous bones may have a transient chondrogenic phase. These innate contradictions can be circumvented if molecular and cellular, rather than histogenic, criteria are used to describe the process of skeletal tissue formation. Within the past decade, clinical examinations of human skeletal syndromes have led to the identification and subsequent characterization of regulatory molecules that direct chondrogenesis and osteogenesis in every skeletal element of the body. In this review, we survey these molecules and the tissue interactions that may regulate their expression. What emerges is a new paradigm, by which we can explain and understand the process of normal- and abnormal-skeletal development.
从传统观点来看,骨骼成分通过两种不同的过程形成:软骨内成骨,在此过程中软骨模板被骨替代;以及膜内成骨,即间充质细胞直接分化为成骨细胞。这种传统分类方案存在一些固有难题,其中最主要的是,通常被描述为软骨内成骨的骨骼实际上是通过膜内过程形成骨的,而且一些膜性骨可能有短暂的软骨生成阶段。如果使用分子和细胞标准而非组织发生标准来描述骨骼组织形成过程,这些内在矛盾是可以避免的。在过去十年中,对人类骨骼综合征的临床检查已导致鉴定并随后表征了指导身体每个骨骼成分软骨生成和成骨的调节分子。在本综述中,我们调查了这些分子以及可能调节其表达的组织相互作用。由此出现了一种新的范例,借此我们可以解释和理解正常和异常骨骼发育的过程。